Mari Ozaki1, Anne M Molloy2, James L Mills3, Ruzong Fan3, Yifan Wang3, Eileen R Gibney4, Barry Shane5, Lawrence C Brody6, Anne Parle-McDermott7. 1. Nutritional Genomics Group, School of Biotechnology, Dublin City University, Dublin, Ireland; 2. Department of Clinical Medicine, School of Medicine, Trinity College Dublin, Dublin, Ireland; 3. Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and. 4. Institute of Food and Health, University College Dublin, Dublin, Ireland; and. 5. University of California, Berkeley, Berkeley, CA. 6. Genome Technology Branch, National Human Genome Research Institute, NIH, Bethesda, MD; 7. Nutritional Genomics Group, School of Biotechnology, Dublin City University, Dublin, Ireland; anne.parle-mcdermott@dcu.ie.
Abstract
BACKGROUND: Dihydrofolate reductase (DHFR) is essential for the conversion of folic acid to active folate needed for one-carbon metabolism. Common genetic variation within DHFR is restricted to the noncoding regions, and previous studies have focused on a 19 bp deletion/insertion polymorphism (rs70991108) within intron 1. Reports of an association between this polymorphism and blood folate biomarker concentrations are conflicting. OBJECTIVE: In this study, we evaluated whether the DHFR 19 bp deletion/insertion polymorphism affects circulating folate biomarkers in, to our knowledge, the largest cohort to address this question to date. METHODS: Healthy young Irish individuals (n = 2507) between 19 and 36 y of age were recruited between February 2003 and February 2004. Folic acid intake from supplements and fortified foods was assessed with the use of a customized food intake questionnaire. Concentrations of serum folate and vitamin B-12, red blood cell (RBC) folate, and plasma total homocysteine (tHcy) were measured. Data were analyzed with the use of linear regression models. RESULTS: Folic acid intake was positively associated with serum (P < 0.0001) and RBC (P = 0.0005) folate concentration and was inversely associated with plasma tHcy (P = 0.001) as expected. The DHFR 19 bp polymorphism was not significantly associated with either serum (P = 0.82) or RBC (P = 0.21) folate, or plasma tHcy (P = 0.20), even in those within the highest quintile of folic acid intake (>326 μg folic acid/d; P = 0.96). A nonsignificant trend toward lower RBC folate by genotype (P = 0.09) was observed in the lowest folic acid intake quintile (0-51 μg/d). CONCLUSION: In this cohort of healthy young individuals, the DHFR 19 bp deletion allele did not significantly affect circulating folate status, irrespective of folic acid intake. Our data rule out a strong functional effect from this polymorphism on blood folate concentrations.
BACKGROUND:Dihydrofolate reductase (DHFR) is essential for the conversion of folic acid to active folate needed for one-carbon metabolism. Common genetic variation within DHFR is restricted to the noncoding regions, and previous studies have focused on a 19 bp deletion/insertion polymorphism (rs70991108) within intron 1. Reports of an association between this polymorphism and blood folate biomarker concentrations are conflicting. OBJECTIVE: In this study, we evaluated whether the DHFR 19 bp deletion/insertion polymorphism affects circulating folate biomarkers in, to our knowledge, the largest cohort to address this question to date. METHODS: Healthy young Irish individuals (n = 2507) between 19 and 36 y of age were recruited between February 2003 and February 2004. Folic acid intake from supplements and fortified foods was assessed with the use of a customized food intake questionnaire. Concentrations of serum folate and vitamin B-12, red blood cell (RBC) folate, and plasma total homocysteine (tHcy) were measured. Data were analyzed with the use of linear regression models. RESULTS:Folic acid intake was positively associated with serum (P < 0.0001) and RBC (P = 0.0005) folate concentration and was inversely associated with plasma tHcy (P = 0.001) as expected. The DHFR 19 bp polymorphism was not significantly associated with either serum (P = 0.82) or RBC (P = 0.21) folate, or plasma tHcy (P = 0.20), even in those within the highest quintile of folic acid intake (>326 μg folic acid/d; P = 0.96). A nonsignificant trend toward lower RBC folate by genotype (P = 0.09) was observed in the lowest folic acid intake quintile (0-51 μg/d). CONCLUSION: In this cohort of healthy young individuals, the DHFR 19 bp deletion allele did not significantly affect circulating folate status, irrespective of folic acid intake. Our data rule out a strong functional effect from this polymorphism on blood folate concentrations.
Authors: Siddharth Banka; Henk J Blom; John Walter; Majid Aziz; Jill Urquhart; Christopher M Clouthier; Gillian I Rice; Arjan P M de Brouwer; Emma Hilton; Grace Vassallo; Andrew Will; Desirée E C Smith; Yvo M Smulders; Ron A Wevers; Robert Steinfeld; Simon Heales; Yanick J Crow; Joelle N Pelletier; Simon Jones; William G Newman Journal: Am J Hum Genet Date: 2011-02-11 Impact factor: 11.025
Authors: Ivon J M van der Linden; Uyen Nguyen; Sandra G Heil; Barbara Franke; Suzanne Vloet; Henkjan Gellekink; Martin den Heijer; Henk J Blom Journal: Mol Genet Metab Date: 2007-03-02 Impact factor: 4.797
Authors: William G Johnson; Edward S Stenroos; John R Spychala; Sansnee Chatkupt; Sue X Ming; Steven Buyske Journal: Am J Med Genet A Date: 2004-02-01 Impact factor: 2.802
Authors: Anna Stanisławska-Sachadyn; Karen S Brown; Laura E Mitchell; Jayne V Woodside; Ian S Young; John M Scott; Liam Murray; Colin A Boreham; Helene McNulty; J J Strain; Alexander S Whitehead Journal: Hum Genet Date: 2008-02-05 Impact factor: 4.132